About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Cadila Gets Tentative USFDA Nod For Pravastatin Sodium Tablets

by Medindia Content Team on June 15, 2006 at 6:56 PM
Font : A-A+

Cadila Gets Tentative USFDA Nod For Pravastatin Sodium Tablets

Cadila Healthcare Ltd has received tentative approval from the USFDA to market Pravastatin Sodium Tablets in the US market.

The tentative approval was given for strengths of 10 mg, 20 mg, 40 mg and 80 mg, the company informed the Bombay Stock Exchange.

Advertisement

The company would market the drug through its US subsidiary Zydus Pharmaceuticals (USA) Inc, following patent expiry, it added.

The drug, which had branded sales of approximately 1.8 billion dollars in the US market during 2005, is a lipid lowering agent.

Source:PTI News
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Top 10 Foods for Decreasing DHT Production and Preventing Hair Fall
Alarming Cesarean Section Trends in India - Convenience or Compulsion of Corporate Healthcare
Quiz on Low-Calorie Diet for Diabetes
View all
Recommended Reading
News Archive
Date
Category
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Hyponatremia Hypochloremia 

Most Popular on Medindia

Color Blindness Calculator Nutam (400mg) (Piracetam) Drug Side Effects Calculator Find a Doctor Blood Pressure Calculator Daily Calorie Requirements Hearing Loss Calculator A-Z Drug Brands in India Turmeric Powder - Health Benefits, Uses & Side Effects Sinopril (2mg) (Lacidipine)
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
ASK A DOCTOR ONLINE

×

Cadila Gets Tentative USFDA Nod For Pravastatin Sodium Tablets Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests